Roivant Sciences
Tracked across 4 events · 31 articles · First seen Mar 03, 2026 · Last active Apr 02, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
NewsDesk Dashboard
Business
Roivant Sciences, as the parent company of Roivant Sciences===Genevant Sciences, benefits from the significant settlement payment. Roivant Sciences has also approved a $1 billion share repurchase program, which may be influenced by this financial influx.
Mar 03, 2026 · 8 articles
Business
Roivant Sciences, as the parent company of Roivant Sciences===Genevant Sciences, benefits from the settlement payment received by its subsidiary. Its shares saw a slight increase following the announcement.
Mar 03, 2026 · 8 articles
Business
Roivant Sciences' subsidiary, Genevant, is a recipient of the settlement payment from Moderna, which could be up to $2.25 billion. This payment is a positive financial outcome for the company.
Mar 04, 2026 · 7 articles
Business
Roivant Sciences will host a conference call to discuss the updates regarding Immunovant's clinical trial results, indicating a relationship or oversight role, likely as a parent company or major shareholder.
Apr 02, 2026 · 8 articles
Roivant Sciences===Genevant Sciences
subsidiary
↔
Roivant Sciences
Roivant Sciences===Genevant Sciences is a subsidiary of Roivant Sciences.
NEWSDESK
Track Roivant Sciences live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard